{"settlement":{"id":"purdue-canada-opioids-2026","slug":"purdue-canada-opioids-2026","title":"Purdue Canada Settlement","category":"Pharmaceutical and Medical Devices","status":"Claims not yet open","tags":{"industry":["Pharmaceutical and medical devices"],"geographic":["Canada-wide"],"recoveryType":["Cash payment"],"documentation":["To be determined"],"eligibilityTrigger":["Was a patient or received treatment"]},"classDefinition":"All persons in Canada, except Excluded Persons, who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class (relatives with standing under s. 61(1) of the Family Law Act or equivalent legislation). Excluded Persons include anyone prescribed only OxyContin or OxyNEO between January 1, 1996 and February 28, 2017 and no other Products, officers or directors of the defendants, and members of the class in the Bourassa Class Action.","plainLanguageSummary":"If you were prescribed or consumed opioid products in Canada, or you are a close relative of someone who was, you may be eligible for a share of a proposed CAD $28,500,000 settlement with Purdue Canada once it is approved by the Court.","eligibilityCriteria":[],"recoveryRange":"Share of a CAD $28,500,000 settlement fund, individual amounts to be determined","filingInstructions":"","caseBackground":"A national class action claims that several pharmaceutical companies promoted opioid medications for chronic conditions starting in the 1990s without properly warning about the risk of addiction. The lawsuit says this led to widespread opioid dependency and addiction among people who were prescribed these medications.\n\nThe plaintiffs have reached a proposed settlement with Purdue Pharma Inc. and Purdue Frederick Inc. (together, Purdue Canada) for a payment of CAD $28,500,000. Purdue Canada denies the allegations and no court has found it liable. The settlement must still be approved by the Ontario Superior Court of Justice at a hearing on September 16, 2026, and the lawsuit continues against the other pharmaceutical companies. A plan for distributing the money to class members is expected later in 2026.","administratorName":"","administratorContacts":[],"administratorRole":"claims","agentName":null,"agentContacts":[],"agentClaimFormHelp":false,"classCounselName":"Koskie Minsky LLP","classCounselContacts":[{"type":"phone","label":"","value":"1-833-630-1776"},{"type":"email","label":"","value":"opioidclassaction@kmlaw.ca"},{"type":"mail","label":"","value":"Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3"},{"type":"online","label":"","value":"https://kmlaw.ca/cases/liability-for-opioid-epidemic/"}],"classCounselFirms":[{"name":"Koskie Minsky LLP","region":"","contacts":[{"type":"phone","label":"","value":"1-833-630-1776"},{"type":"email","label":"","value":"opioidclassaction@kmlaw.ca"},{"type":"mail","label":"","value":"Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3"},{"type":"online","label":"","value":"https://kmlaw.ca/cases/liability-for-opioid-epidemic/"}]}],"submissionMethods":[],"sourceDocuments":[{"url":"/uploads/e92de0683ad72371bf7a41d9-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Purdue_Mar_26.pdf","title":"Notice to Class Members"},{"url":"/uploads/ec7d52096cd61b23395e122f-ng-Form-Notice_of_Certification_and_Settlement_Approval_Hearing_Purdue_FR_Mar_26.pdf","title":"Avis aux membres du groupe"}],"shortFormNoticeUrl":"/uploads/98829dd0b04485f56d203d6e-Short_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Purdue_Mar_26.pdf","longFormNoticeUrl":"/uploads/e92de0683ad72371bf7a41d9-Long_Form_Notice_of_Certification_and_Settlement_Approval_Hearing_Purdue_Mar_26.pdf","settlementAgreementUrl":"","claimFormDocumentUrl":"","claimForms":[],"claimFormsButtonLabel":"claim-form","claimFormsUnavailable":false,"claimFormsUnavailableReason":null,"claimFormGuides":[],"additionalDocuments":[],"optOutFormUrl":"","optOutInstructions":"To opt out, you must send a completed Opt Out Request to Class Counsel on or before May 4, 2026, by email to opioidclassaction@kmlaw.ca or by mail to Re: Opioids Class Action, Koskie Minsky LLP, 20 Queen Street West, Suite 900, Toronto, ON, M5H 3R3. The Opt Out Request form is available from Class Counsel. The opt-out deadline of May 4, 2026 has now passed.","objectionFormUrl":null,"objectionInstructions":null,"faqs":[{"answer":"Purdue Canada has agreed to pay CAD $28,500,000 to settle the claims against it. Individual payment amounts have not been determined yet; a distribution plan is expected to be proposed to the Court later in 2026.","question":"How much money is in the settlement?"},{"answer":"Not yet. The settlement must first be approved by the Court at a hearing on September 16, 2026. If it is approved, further information will be provided about how to make a claim for compensation. You can register at opioidclassaction@kmlaw.ca to receive future notices.","question":"When can I make a claim?"},{"answer":"No. The deadline to submit an Objection Form or an Opt Out Request to Class Counsel was May 4, 2026, and it has passed.","question":"Can I still object to the settlement or opt out?"},{"answer":"If you do nothing, you remain in the class. If the Court approves the settlement, you will be eligible to make a claim for compensation but will not be able to sue Purdue Canada individually about the claims the settlement resolves.","question":"What happens if I do nothing?"},{"answer":"No. Class members are not charged for Class Counsel's services. Class Counsel will ask the Court to approve a fee of 25% of the settlement funds, and a court-approved litigation funder will receive a return of 11% of the settlement funds and related costs.","question":"Do I have to pay the lawyers?"}],"eligibilityChecker":{"questions":[{"id":"prescribed-or-consumed-opioids","text":"Were you prescribed or did you consume any opioid product in Canada, or are you the heir of someone who was, or a family member with a claim through them?","type":"yes_no","helpText":"Family members may qualify under family law legislation because of their relationship to a person who took opioids.","qualifyingAnswer":"yes","criticalForEligibility":true},{"id":"only-oxycontin-oxyneo","text":"Were you prescribed only OxyContin or OxyNEO in Canada between January 1, 1996 and February 28, 2017, and no other opioid products during the class period?","type":"yes_no","helpText":"People whose only prescriptions were OxyContin or OxyNEO in that period are excluded because they are covered by a different class action.","qualifyingAnswer":"no","criticalForEligibility":true},{"id":"officer-or-director","text":"Are you an officer or director of any of the defendant pharmaceutical companies?","type":"yes_no","qualifyingAnswer":"no","criticalForEligibility":true},{"id":"bourassa-class-member","text":"Are you a member of the class in the Bourassa Class Action?","type":"yes_no","qualifyingAnswer":"no","criticalForEligibility":true}],"uncertainMessage":"Some of your answers were Not sure, so we could not confidently determine your eligibility.","qualifyingMessage":"Based on your answers, you appear to fall within the class definition for this settlement.","nonQualifyingMessage":"Based on your answers, you do not appear to fall within the class definition for this settlement."},"claimCategories":[],"proceedings":null,"relatedSlugs":[],"group":{"slug":"opioid-class-action","title":"Opioid Class Action","summary":"Three proposed settlements with Purdue Canada, Valeant and Mylan in the national opioid class action, Gebien v. Apotex, brought on behalf of Canadians who were prescribed or consumed opioid products and allege opioid dependency or addiction. Each settling defendant denies the allegations and the class action continues against the remaining defendants.","membersIntro":null,"structure":"multi_settlement","members":[{"slug":"purdue-canada-opioids-2026","title":"Purdue Canada Settlement","classDefinition":"All persons in Canada, except Excluded Persons, who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class (relatives with standing under s. 61(1) of the Family Law Act or equivalent legislation). Excluded Persons include anyone prescribed only OxyContin or OxyNEO between January 1, 1996 and February 28, 2017 and no other Products, officers or directors of the defendants, and members of the class in the Bourassa Class Action.","status":"Claims not yet open","geographic":["Canada-wide"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":true},{"slug":"valeant-opioid-settlement-2026","title":"Valeant and Bausch Health Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid product (as defined in the Settlement Agreement), together with their heirs, and any member of the Family Law Class. The Family Law Class includes persons who, by reason of a relationship to a Class Member, have standing under section 61(1) of the Family Law Act or equivalent legislation.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false},{"slug":"national-opioids-mylan-2026","title":"Mylan Settlement","classDefinition":"All persons in Canada (except Quebec) who were prescribed or consumed any opioid Product, together with their heirs, and any member of the Family Law Class. The Family Law Class includes all persons in Canada who, by reason of a relationship to a Class Member, have standing under section 61(1) of Ontario's Family Law Act or equivalent legislation in another province or territory, or the common law.","status":"Claims not yet open","geographic":["Canada-wide (Except Quebec)"],"deadline":"","lastVerifiedAt":"2026-08-16","isSelf":false}]},"cardSummary":"If you took prescription opioids in Canada, or a close family member did, a proposed $28.5 million settlement with Purdue Canada may affect you. Claims have not opened yet.","proofRequired":"","claimTime":"","claimAmount":"","coverageStartDate":"","coverageEndDate":"","deadline":"","optOutDeadline":"2026-05-04","objectionDeadline":null,"approvalHearingDate":"2026-09-16","approvalHearingDates":[{"date":"2026-09-16","label":""}],"approvalPending":false,"seriousHarmEnabled":false,"formHelperEnabled":false,"dateAdded":"2026-08-16","lastUpdated":"2026-08-16","firstPublishedAt":"2026-08-16 16:05:08","claimsOpenedAt":null,"lastVerifiedAt":"2026-08-16","languages":["en","fr"]}}